Egstrup, Kenneth

Defibrillator implantation in patients with nonischemic systolic heart failure

Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine

Cardiac pacing and defibrillation studiesCardiac Arrest and Resuscitation

Cited by 1,763

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthCardiac Valve Diseases and Treatments

Cited by 1,644

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Bhatt, D. L., Steg, P. G., Mehta, S. R., Leiter, L. A., Simon, T., Fox, K., Held, C., Andersson, M., Himmelmann, A., Ridderstråle, W., et al. (2019) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 209

Five-year outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial

Lindholt, J. S., Søgaard, R., Rasmussen, L. M., Mejldal, A., Lambrechtsen, J., Steffensen, F. H., Frost, L., Egstrup, K., Urbonaviciene, G., Busk, M., et al. (2022) · New England Journal of Medicine

Health Promotion and Cardiovascular PreventionCardiac Imaging and Diagnostics

Cited by 182

Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy

Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 44

Effect modifications of lipid-lowering therapy on progression of aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study)

Greve, A. M., Bang, C. N., Boman, K., Egstrup, K., Forman, J. L., Kesäniemi, Y. A., Ray, S., Pedersen, T. R., Best, P., Rajamannan, N. M., et al. (2018) · The American Journal of Cardiology

Cardiac Valve Diseases and TreatmentsLipoproteins and Cardiovascular Health

Cited by 34

Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty

Hofsten, D. E., Wachtell, K., Lund, B., Molgaard, H., Egstrup, K., & on behalf of the DANAMI-2 Investigators (2007) · European Heart Journal

Acute Myocardial Infarction ResearchCardiac Arrhythmias and Treatments

Cited by 27